Academic literature on the topic 'Queen Charlotte Group (B C )'

AbstractThe Queen Charlotte Fault defines the Pacific–North America transform plate boundary in western Canada and southeastern Alaska for c. 900 km. The entire length of the fault is submerged along a continental margin dominated by Quaternary glacial processes, yet the geomorphology along the margin has never been systematically examined due to the absence of high-resolution seafloor mapping data. Hence the geological processes that influence the distribution, character and timing of mass transport events and their associated hazards remain poorly understood. Here we develop a classification of the first-order shape of the continental shelf, slope and rise to examine potential relationships between form and process dominance. We found that the margin can be split into six geomorphic groups that vary smoothly from north to south between two basic end-members. The northernmost group (west of Chichagof Island, Alaska) is characterized by concave-upwards slope profiles, gentle slope gradients (<6°) and relatively low along-strike variance, all features characteristic of sediment-dominated siliciclastic margins. Dendritic submarine canyon/channel networks and retrogressive failure complexes along relatively gentle slope gradients are observed throughout the region, suggesting that high rates of Quaternary sediment delivery and accumulation played a fundamental part in mass transport processes. Individual failures range in area from 0.02 to 70 km2 and display scarp heights between 10 and 250 m. Transpression along the Queen Charlotte Fault increases southwards and the slope physiography is thus progressively more influenced by regional-scale tectonic deformation. The southernmost group (west of Haida Gwaii, British Columbia) defines the tectonically dominated end-member: the continental slope is characterized by steep gradients (>20°) along the flanks of broad, margin-parallel ridges and valleys. Mass transport features in the tectonically dominated areas are mostly observed along steep escarpments and the larger slides (up to 10 km2) appear to be failures of consolidated material along the flanks of tectonic features. Overall, these observations highlight the role of first-order margin physiography on the distribution and type of submarine landslides expected to occur in particular morphological settings. The sediment-dominated end-member allows for the accumulation of under-consolidated Quaternary sediments and shows larger, more frequent slides; the rugged physiography of the tectonically dominated end-member leads to sediment bypass and the collapse of uplifted tectonic features. The maximum and average dimensions of slides are an order of magnitude smaller than those of slides observed along other (passive) glaciated margins. We propose that the general patterns observed in slide distribution are caused by the interplay between tectonic activity (long- and short-term) and sediment delivery. The recurrence (<100 years) of M > 7 earthquakes along the Queen Charlotte Fault may generate small, but frequent, failures of under-consolidated Quaternary sediments within the sediment-dominated regions. By contrast, the tectonically dominated regions are characterized by the bypass of Quaternary sediments to the continental rise and the less frequent collapse of steep, uplifted and consolidated sediments.

In this study, the retinue pheromones (9-ODA, R and S HDA, HOB, HVA, methyl oleate, conyferyl alcohol, palmityl alcohol and linolenic acid) of Caucasian and Aegean Ecotype of Anatolian queens stored in Kirchain mating boxes and Reservoir colonies were determined. After the queens beginning egg lying for 102 days was collected individually in eppendorf tubes and stored at -20°C until the analysis (group A). Second group queens (10 Aegean and 10 Caucasian) collected from Kirchain mating boxes in the same day stored 25 days in the reservoir colonies (B group). Also, the queens in the last group (10 Aegean and 10 Caucasian) were collected after beginning egg lying for 352 days (C group). After all, the queens in the group B and C put individually in eppendorf tubes and stored at -20°C until the analysis. Pheromones in the head, chest and abdomen of the stored queens were identified by gas chromatography. According to results, the differences in the values of 9 ODA and 9 HDA for were statistically insignificant for queen breeding season, application groups (A, B and C) and genotypes, but differences in body parts were determined to be statistically significant. The differences between HOB and HVA values were also statistically insignificant for queen breeding season, application groups, genotype and body parts. In the study, the effects of application group, genotype and body parts on the amount of linoleic acid were determined to be statistically significant. Linolenic acid secreted higher from the abdomen than that of the head and chest, and the differences among the body parts were also statistically significant. In general, 9 ODA and 9 HDA amounts were secreted the highest in the head of the queens, HOB and HVA were secreted equally amounts in the three parts of the body, and linolenic acid was secreted the highest from the abdomen. The queens allowed egg lying for 352 days in Kirchain mating boxes were secreted 9 ODA, 9 HDA, HOB and HVA more than the queens allowed egg lying for 102 days and stored reservoir colonies.

The study area marks the south-eastern extremity of the Mulug Coal Belt of Godavari Valley Coalfield, Telangana. The Bore-hole No. KYG-353, containing Index above Queen and Queen seams, is located in north-western direction from Kothagudem Town of Khammam District. The petrographic analysis has been done to ascertain their rank by random vitrinite reflectance (Ro mean %) measurements and quality estimation through maceral analysis, in order to interpret the environment of deposition as well as economic significance. The Index above Queen Seam has vitrinite group of maceral in dominance therefore, contains vitric type of coal whereas; the top and a band in the middle part of the Queen Seam contain coal which is fusic (inertinite rich) in nature. The bottom part of this seam has shown vitrinite in abundance indicating its vitric nature. The random vitrinite reflectance (Ro mean %) study has revealed that the coals of Index above Queen and the Queen seams have attained high volatile bituminous C stage of rank, except for a coal band located between 161.44 m and 162.44 m depth range, which has reached high volatile bituminous B rank. It is also inferred that the vegetal resource of Index above Queen Seam has been deposited during oxic and anoxic moor conditions; however, a distinct change in the climatic conditions to oxic moor with intermittent moderate to high flood situation occurred in the depositional phase of the Queen Seam. The study also suggests that coal deposits in this region have significantly high economic potentials.

Introduction: Preoperative prognostic predictors are important for surgeons and parents to estimate the survival of patients with esophageal atresia (EA). The aim of this study was to update the clinical outcomes of EA treatment by comparing between the Waterston and the Spitz classification. Materials and Methods: Medical records of the patients with EA treated at Queen Sirikit National Institute of Child Heath from 2003 to 2010 were reviewed. All of the patients were categorised into 3 groups of the Waterston and 3 groups of the Spitz risk factor criteria for comparing of the differences in each group and each classification. Results: One hundred and thirty-two patients (81 males and 61 females) were treated for EA during the study period. Applying the Waterston classification, survival rate was 100% in group A, 91.5% in group B and 48.8% in group C. There was no statistical difference between the survival rate in group A and group B (P = 0.119) but significant difference between group B and group C (P = 0.000). Using the Spitz classification, survival rate was 97.4% in group I, 64.4% in group II and 27.3% in group III. There was obviously statistical difference of the survival rate between each group (group I vs group II, P = 0.000; group II vs group III, P = 0.041). Conclusion: Comparing with the prognostic predictors, the Spitz classification was more valid than the Waterston criteria. The Spitz classification is suitable to use for preoperative predictor to parental counselling and comparing of treatment outcomes of EA among paediatric tertiary care centres. Key words: Tracheoesophageal fistula, Risk factor, Prognostic predictor, Classification

AbstractAlpha-linolenic acid (ALA), which is an n-3 polyunsaturated fatty acid (PUFA), influences honey bee feed intake and longevity. The objective of this study was to research the effect of six dietary ALA levels on the growth and development of Apis mellifera ligustica colonies. In the early spring, a total of 36 honey bee colonies of equal size and queen quality were randomly allocated into 6 groups. The six groups of honey bees were fed a basal diet with supplementation of ALA levels at 0 (group A), 2 (group B), 4 (group C), 6 (group D), 8 (group E), and 10% (group F). In this study, there were significant effects of pollen substitute ALA levels on the feeding amounts of the bee colony, colony population, sealed brood amount, and weight of newly emerged workers (P<0.05). The workers’ midgut Lipase (LPS) activity of group C was significantly lower than that of the other groups (P<0.01). The worker bees in groups B, C, and D had significantly longer lifespans than those in the other groups (P<0.05). However, when the diets had ALA concentrations of more than 6%, the mortality of the honey bees increased (P<0.01). These results indicate that ALA levels of 2 ~ 4% of the pollen substitute were optimal for maintaining the highest reproductive performance and the digestion and absorption of fatty acids in honey bees during the period of spring multiplication. Additionally, ALA levels of 2 ~ 6% of the pollen substitute, improved worker bee longevity.

Diploid japanese plum (Prunus salicina Lindl.) cultivars are commonly self-incompatible. To date, 14 incompatibility alleles (S-alleles) have been identified and labeled with alphabetical (S a-S n) and 5 with numeric codes (S 1, S 3-S 6). We applied polymerase chain reaction amplification of the S-RNase alleles with degenerate and allele-specific primers in 10 japanese plum cultivars and two pluots of unknown incompatibility alleles. Besides DNA sequencing, an additional method for the exact length determination of the first intron region was used for the first time for S-genotype japanese plums. The S 3-allele was shown to correspond to S k in the alphabetic nomenclature, S 4 to S c, S 5 to S e, and S 6 to S f. The S 5-allele-specific primer can be used as a reliable marker for self-compatibility in japanese plum. ‘Black Amber’, ‘October Sun’, ‘TC Sun’, and ‘Super Giant’ share the S b S c genotype, which was confirmed by test crosses. These cultivars belong to the widest incompatibility group currently known in japanese plum. An additional incompatibility group (S c S h) was established, including ‘Green Sun’ and ‘Queen Rosa’, a cultivar formerly known as a universal donor. By incorporating all previous and recent results, a table was assembled including 49 cultivars assigned to I–VII incompatibility groups, to the self-compatible group and to the group O of unique genotypes. These data may considerably contribute to further growing and breeding activities.

BackgroundThe 4-week in-patient Multi-Disciplinary Team Service at Queen Square for patients with Functional Neurological Symptom Disorder (FNSD) has input from Neuropsychiatrists, Occupational Therapists, Physiotherapists, Cognitive Behavioural Therapists, and specialist nursing staff.The Queen Square Guided Self-Help (QGSH) was developed as a brief therapeutic intervention, which aims to ensure that, prior to admission, the patient understands (a) the diagnosis of FNSD and how their own diagnosis has been reached; (b) rehabilitation therapy, both physical and psychological, and (c) the use of goal setting in rehabilitation.The QGSH is a course of Internet-based guided self-help. It runs for up to 12 weeks and includes original videos and patient worksheets, as well as signposting to existing published resources. It involves therapists guiding the patient to use a range of psychoeducational resources and facilitating therapy activities, supported by one-to-one contact via email or phone-calls.With the emergence of the covid pandemic and the first lockdown (March 2020) plus the growing patient waiting lists, we decided to offer the QGSH (i) remotely via zoom (ii) to groups of patients instead of individuals. This required a complete review of the QGSH goals, format, aims and objectives which resulted in a number of modifications including extensive revisions to the current materials.Aim of this studyWe present a service evaluation of the first 8 months of running QGSH therapy groups remotely on zoom.Results(1) We present the modifications we made to the existing QGSH materials which were finalised in April 2021.(2) In the period 11-May-2021 to 31-Jan-2022 we ran three groups with a total of 16 participants.(3) We present challenges and advantages from the perspective of the patients and from the perspective of the QGSH therapists.(4) Drawing on the published literature (Rogers, Yalom) plus our experiences as senior therapists, we outline the specialist knowledge, skills and competencies required to run a therapeutic group with patients with FNSD.DiscussionFeedback from the patients who participated in the groups was overwhelmingly positive. From the patients’ comments, the group furnished 8/11 of Yalom’s curative factors. We outline our plans for the future development of the QGSH preparatory therapy and a new initiative: the development of a ‘stand-alone’ group therapy for patients with FNSD.

BACKGROUND: DLBCL is the most common and a potentially curable non-Hodgkin lymphoma. Multiple previous studies have shown that minority populations have worse outcomes compared to Caucasians (Tao L, Blood 2014; Griffiths R, BMC Cancer 2010; Koroukian et al, Cancer, 2010, Shenoy PJ Cancer 2010). Moreover, it has been reported that uninsured and Medicaid insured patients with DLBCL have inferior survival compared to privately insured patients (Han X, Cancer 2014; Koroukian et al, Cancer 2010;). It has also been well established that minorities are underrepresented in clinical trials (Gerrero S, Sci Rep 2018; Kwiatkowski K, Cancer 2013). We present the baseline characteristics, treatment paradigms and outcomes of Caucasian (C) and non-Caucasian (NC) patients with de novo DLBCL treated at a single academic hybrid cancer center. METHODS: We collected demographic, disease, insurance coverage, treatment characteristics, and treatment outcomes for patients with de novo DLBCL who presented between January 2016 and January 2019 at Levine Cancer Institute, Charlotte, North Carolina. Patient race, C or NC were self-reported. Insurance was categorized as Government (Medicaid or Medicare), Private, or Uninsured. We used the Revised International Prognostic Index (R-IPI) to risk stratify patients. Double-hit lymphomas (DHL) were defined as having the MYC translocation with either BCL2 or BCL6 translocation on fluorescent in situ hybridization. Treatments included standard chemoimmunotherapies, stem cell transplantation and clinical trials including chimeric antigen receptor therapies (CART). Outcomes of overall survival (OS) and progression free survival (PFS) were calculated using the Kaplan Meier method and compared with log rank test. Demographic data was compared using Fisher's Exact tests. RESULTS: One hundred and ninety-six consecutive patients with de novo DLBCL were included in the analysis [155 (79%) = C, 41 (21%) = NC] (Table). The NC group was predominantly African American (71%) followed by Hispanic (15%). Prognostic scores (R-IPI) and the incidence of DHL were similar between C and NC. The median age at diagnosis in the NC group was lower than in C. There were significant differences in insurance coverage between the 2 groups (p=0.012). The C group did not have any uninsured patients and had more patients with private insurance (33%) compared to the NC group (7% uninsured and 27% with private insurance). The most common frontline treatment was RCHOP (C=66%, NC=70%) followed by dose adjusted REPOCH (C=12%, NC=15%). Median follow up was 31.6 months. There was no difference in OS and PFS between the 2 groups (Figure 1). OS at 2 years from date of diagnosis was 81% for C and 84% for NC, p=0.852. Two-year PFS from time of diagnosis were similar for both groups: 61% for C and 63% for NC, p=0.999. Similar numbers of patients in both groups developed relapsed or refractory (R/R) disease after frontline therapy. Median number of treatments was 2 for both groups, p=0.582. For patients who developed R/R DLBCL, the 2-year OS was 60% for C and 63% for NC, p=0.590. Similar proportions underwent stem cell transplantation: 11% for C and 20% for NC, p= 0.186. Clinical trial enrollment was comparable: 11% for C and 12% for NC, p=0.785. CONCLUSION: Unlike previous population-based studies that have shown racial disparities with superior outcomes for Caucasians and for patients with private insurance, our single center experience demonstrates similar survival outcomes between Caucasians and non-Caucasians diagnosed with de novo DLBCL, despite differences in insurance coverage favoring Caucasians. In the R/R setting, similar proportions of both groups underwent stem cell transplantation and enrolled on clinical trials. The likely explanation is that our safety net cancer center, with extensive nurse navigator support and access to standard treatments, stem cell transplants and cutting-edge clinical trials may abrogate the inferior outcomes in minority populations that have been previously reported. Disclosures Symanowski: Immatics: Consultancy; Eli Lilly: Consultancy; Carsgen Therapeutics: Consultancy; Boston Biomedical: Consultancy. Park:Rafael Pharma: Membership on an entity's Board of Directors or advisory committees; BMS: Consultancy, Research Funding; Gilead: Speakers Bureau; Teva: Consultancy, Research Funding; G1 Therapeutics: Consultancy; Seattle Genetics: Research Funding, Speakers Bureau. Avalos:Juno: Membership on an entity's Board of Directors or advisory committees; Best Practice-Br Med J: Patents & Royalties: receives royalties from a coauthored article on evaluation of neutropenia. Jacobs:Genentech: Speakers Bureau; AstraZeneca: Speakers Bureau; TG Therapeutics: Honoraria, Research Funding; AbbVie: Consultancy, Speakers Bureau; JUNO: Consultancy; Gilead: Consultancy; Pharmacyclics LLC, an AbbVie Company: Research Funding, Speakers Bureau. Ghosh:TG Therapeutics: Consultancy, Honoraria, Research Funding; SGN: Consultancy, Honoraria, Research Funding, Speakers Bureau; Bristol-Myers Squibb: Honoraria, Speakers Bureau; Gilead: Consultancy, Honoraria, Speakers Bureau; Janssen: Consultancy, Honoraria, Research Funding, Speakers Bureau; Pharmacyclics LLC, an AbbVie Company: Consultancy, Honoraria, Research Funding, Speakers Bureau; Celgene: Consultancy, Research Funding; Genentech: Research Funding; AstraZeneca: Honoraria, Speakers Bureau; Forty Seven Inc: Research Funding.

BACKGROUND: The dress code for surgeons has evolved over time from formal suit-and-tie to crisp white coat, and currently to various forms of smart-casual attire; however, there is no stipulated or rigid uniform guideline. It is important to explore and discuss the various forms of attire in relation to patients' ideals and perceptions of a surgeon. METHODS: An observational study in the form of a paper-based questionnaire was carried out at the Charlotte Maxeke Johannesburg Academic Hospital (CMJAH), Chris Hani Baragwanath Academic Hospital (CHBAH) and Wits Donald Gordon Medical Centre (WDGMC). Seven questions (Q1-Q7) were posed with various dress categories to select from in each question, namely: formal, smart, smart-casual and scrubs. Descriptive analysis of the survey responses, and the determination of the association between survey responses and a) hospital, b) gender, c) age group was performed. Fisher's exact test was used where the requirements for the chi-square test could not be met. Attire groups with n < 15 were not analysed. The strength of the associations was measured by Cramer's V and the phi coefficient respectively. Data analysis was carried out using SAS v9.4 for Windows. A 5% significance level was used. RESULTS: A total of 387 questionnaires were filled out with a total of 376 fully completed and eligible samples in consenting participants of 18 years and older. In all seven questions, scrubs were the preferred attire. Overall, for Q1-Q5 and Q7, after scrubs, smart was the next most popular attire. For Q6, after scrubs, smart, smart-casual and formal were all popular, indicating some leeway on weekends and public holidays. There was a significant association between each of the responses to the question and hospital (p < 0.0001). At CHBAH, patients preferred scrubs more and smart attire less, compared to CMJAH and WDGMC. At CMJAH, preference for formal attire was greater when compared to the other two hospitals. CONCLUSION: Overall, patients preferred their surgeons to be dressed in scrubs as this attire easily identified surgeons and instilled confidence in the wearer.

Background:Sandoz etanercept (SDZ ETN) is a biosimilar of etanercept (ETN). COMPACT is an ongoing, non-interventional study, evaluating the effectiveness, safety, and quality of life with SDZ ETN treatment in patients (pts) with rheumatoid arthritis (RA), axial-spondyloarthritis (axSpA) or psoriatic arthritis (PsA) in real-world conditions.Objectives:We have reported an interim analysis, with the effectiveness and safety data focusing on pts who were in clinical remission or low disease activity under treatment with reference ETN or biosimilar ETN other than SDZ ETN (initial ETN; iETN) and switched to SDZ ETN.Methods:Pts aged ≥18 years for whom treatment with SDZ ETN were initiated are being enrolled. Pts were categorized under four treatment groups based on prior treatment status: Group A,pts on clinical remission or low disease activity under treatment with iETN and switched to SDZ ETN; Group B, pts who received targeted therapies and switched to SDZ ETN; Group C, biologic naïve considered uncontrolled with conventional therapy; Group D, DMARD naïve with recent diagnosis of RA considered suitable for treatment initiation with a biologic and started on treatment with SDZ ETN. Effectiveness assessments included Disease Activity Score 28-joint count Erythrocyte Sedimentation Rate (DAS28-ESR) or Ankylosing Spondylitis Disease Activity Score (ASDAS) until Week 24 after enrollment (baseline; BL) in the study. Functional disability was measured by the Health Assessment Questionnaire Disability Index (HAQ-DI). The effectiveness and safety results are reported for the pts who switched from iETN (Group A).Results:Of the 1437 pts recruited (analysis cut-off date: 16 Oct, 2020), 567 pts were switched from iETN, 163 were switched from other targeted therapies, 697 were biologic-naïve, and 10 were RA DMARD-naïve. Among pts who switched from iETN, 51.5% had RA, followed by axSpA (28.0%) and PsA (20.5%). Comorbidities were more frequent in pts with RA (70.2%) followed by PsA (58.6%) and axSpA (49.7%); musculoskeletal and connective tissue disorders were reported in 31.8% and 15.7% of pts with RA and axSpA, respectively. At BL, whilst receiving iETN, the mean (SD) DAS28-ESR scores were 2.5 (1.1) and 2.1 (1.1) in pts with RA and PsA, respectively (figure 1). The mean change from BL in DAS28-ESR score at Week 24 after switch to SDZ ETN was -0.1 (1.1) and 0 (1.0) in pts with RA and PsA, respectively. In pts with axSpA, the mean (SD) ASDAS score was 1.5 (0.7) at BL; mean change from BL in ASDAS score at Week 24 was 0.1 (0.5). At BL, the mean (SD) HAQ-DI scores were 0.8 (0.7), 0.5 (0.7) and 0.5 (0.6) in pts with RA, PsA and axSpA, respectively. Overall, the proportion of patients with at least one adverse event (AE) was 37.3%, 33.6% and 25.8% in pts with RA, PsA and axSpA, respectively. Serious AEs were reported in 6.5%, 1.7% and 3.1% of pts with RA, PsA, and axSpA, respectively. Injections site reactions were reported in 2.7%, 0.9% and 1.3% of pts with RA, PsA and axSpA, respectively.Figure 1.Disease activity in patients who switched from iETN to SDZ ETNConclusion:The interim analysis results shows that switch from iETN to SDZ ETN does not impact the effectiveness of ETN in pts with RA, axSpA or PsA, without any new safety signals.Disclosure of Interests:Marc Schmalzing Speakers bureau: Novartis, AbbVie, Chugai/Roche, Janssen-Cilag, Lilly, Consultant of: AstraZeneca, Chugai/Roche, Hexal/Sandoz, Gilead, AbbVie, Janssen-Cilag, Boehringer/Ingelheim, Grant/research support from: Travel grants: Chugai/Roche, Boehringer/Ingelheim, Celgene, Medac, Ayman Askari: None declared, Tom Sheeran Speakers bureau: Pfizer, UCB, Roche, Consultant of: Novartis, Pfizer, Grant/research support from: Novartis, UCB, Roche, David Walsh: None declared, Javier de Toro Santos: None declared, JULIO CESAR VAZQUEZ PEREZ-COLEMAN Speakers bureau: Sandoz, Abbvie, Sanofi, Fresenius, Charlotte Both Employee of: Sandoz employee Global Medical Affairs, Fabricio Furlan Employee of: Sandoz employee Global Medical Affairs, Sohaib HACHAICHI Employee of: Sandoz employee Global Medical Affairs, Herbert Kellner: None declared

Andrew Choo’s Evidence provides an account of the core principles of the law of civil and criminal evidence in England and Wales. It also explores the fundamental rationales that underlie the law as a whole. The text explores current debates and draws on different jurisdictions to achieve a mix of critical and thought-provoking analysis. Where appropriate the text draws on comparative material and a variety of socio-legal, empirical, and non-legal material. This (sixth) edition takes account of revisions to the Criminal Procedure Rules, the Criminal Practice Directions, and the Police and Criminal Evidence Act Codes of Practice. It also examines in detail cases on various topics decided since the last edition was completed, or the significance of which has become clear since then, including: • Addlesee v Dentons Europe llp (CA, 2019) (legal professional privilege) • Birmingham City Council v Jones (CA, 2018) (standard of proof) • R v B (E) (CA, 2017) (good character evidence) • R v Brown (Nico) (CA, 2019) (hearsay evidence) • R v C (CA, 2019) (hearsay evidence) • R v Chauhan (CA, 2019) (submissions of ‘no case to answer’) • R v Gabbai (Edward) (CA, 2019) (bad character evidence) • R v Gillings (Keith) (CA, 2019) (bad character evidence) • R v Hampson (Philip) (CA, 2018) (special measures directions) • R v K (M) (CA, 2018) (burden of proof) • R v Kiziltan (CA, 2017) (hearsay evidence) • R v L (T) (CA, 2018) (entrapment) • R v Reynolds (CA, 2019) (summing-up) • R v S (CA, 2016) (hearsay evidence) • R v SJ (CA, 2019) (expert evidence) • R v Smith (Alec) (CA, 2020) (hearsay evidence) • R v Stevens (Jack) (CA, 2020) (presumptions) • R v Townsend (CA, 2020) (expert evidence) • R v Twigg (CA, 2019) (improperly obtained evidence) • R (Jet2.com Ltd) v CAA (CA, 2020) (legal professional privilege) • R (Maughan) v Oxfordshire Senior Coroner (SC, 2020) (standard of proof) • Serious Fraud Office v Eurasian Natural Resources Corpn Ltd (CA, 2018) (legal professional privilege) • Shagang Shipping Co Ltd v HNA Group Co Ltd (SC, 2020) (foundational concepts; improperly obtained evidence) • Stubbs v The Queen (PC, 2020) (identification evidence) • Volaw Trust and Corporate Services Ltd v Office of the Comptroller of Taxes (PC, 2019) (privilege against self-incrimination) • Volcafe Ltd v Cia Sud Americana de Vapores SA (SC, 2018) (burden of proof)